GENE ONLINE|News &
Opinion
Blog

Max Heirich

WRITTEN BY Max Heirich

Bristol Myers Squibb’ sNDA for Rare Heart Disease Treatment Accepted by the FDA
2022-10-21
Illumina Teams Up With GenoScreen in Eradicating Tuberculosis
2022-10-19
Transforming Southern California Biotech Landscape: An Interview With SoCalBio CEO Ahmed Enany
2022-10-18
Eli Lilly Snatches Up Akouos Treating Ear Conditions for $487 million
2022-10-18
Nineteen Grants and Two Contracts Grab $38 Million In Support From the FDA
2022-10-17
Gilead and MacroGenics Strike Potential $1.7 billion Collaboration Over Bispecific Antibodies
2022-10-17
Novo Nordisk Finally Finalizes their Billion Dollar Acquisition of Forma Therapeutics
2022-10-14
EMA Signals Positive Opinion for Regeneron’s Cervical Cancer Monotherapy
2022-10-14
FDA Accepts Resubmission of BioMarin’s Gene Therapy Two Years After Rejection
2022-10-13
Ginkgo Bioworks and Merck’s Collaboration Worth Up to $144 million
2022-10-13
Will Biden’s Biomanufacturing Initiative Kill Korean Partnership?
2022-10-12
Pfizer/BioNTech’s Omicron Booster Snags Another FDA Emergency Use Authorization
2022-10-12
Action Date Set for Gilead Sciences’ HR+/HER2- breast cancer sBLA
2022-10-11
Though Alzheimer’s Treatment Fails Presenting Primary Endpoints, TauRx is Still Seeking Approval
2022-10-06
FDA Accepts and Boosts sBLA for Takeda’s HAE Treatment for Pediatric Patients
2022-10-06
1 2 3 4 … 9
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top